[
  {
    "ts": null,
    "headline": "3 Dividend Stocks to Double Up on Right Now",
    "summary": "AbbVie is a Dividend King that's poised for accelerating growth.  Enterprise Products Partners offers an ultra-high distribution yield with domestic and international growth drivers.  Realty Income has increased its dividend 131 times over the last 30 years and is targeting a huge potential market.",
    "url": "https://finnhub.io/api/news?id=cd57269b50a138ae2df1bad9da39583cddf1d84241ebe9e527d6e2e04224d91f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751187060,
      "headline": "3 Dividend Stocks to Double Up on Right Now",
      "id": 135629608,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "AbbVie is a Dividend King that's poised for accelerating growth.  Enterprise Products Partners offers an ultra-high distribution yield with domestic and international growth drivers.  Realty Income has increased its dividend 131 times over the last 30 years and is targeting a huge potential market.",
      "url": "https://finnhub.io/api/news?id=cd57269b50a138ae2df1bad9da39583cddf1d84241ebe9e527d6e2e04224d91f"
    }
  },
  {
    "ts": null,
    "headline": "Best Dividend Aristocrats For July 2025",
    "summary": "Best Dividend Aristocrats For July 2025",
    "url": "https://finnhub.io/api/news?id=0b91450584c711e2485a33bfe300de3807c5ee9005c10f315f854c4ead198f45",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751181558,
      "headline": "Best Dividend Aristocrats For July 2025",
      "id": 135631077,
      "image": "",
      "related": "ABBV",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=0b91450584c711e2485a33bfe300de3807c5ee9005c10f315f854c4ead198f45"
    }
  },
  {
    "ts": null,
    "headline": "Merck: Don't Let Today's Bargain Opportunity Pass You By",
    "summary": "Merck remains a top Big Pharma name with strong leadership, rising sales, and high margins, despite regulatory fears and pressures. Learn why MRK stock is a buy.",
    "url": "https://finnhub.io/api/news?id=ef8150d08e342399dd1513b3199ce82a7da44d655618d5191c837c31591dc9bb",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751168314,
      "headline": "Merck: Don't Let Today's Bargain Opportunity Pass You By",
      "id": 135628039,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1249038014/image_1249038014.jpg?io=getty-c-w1536",
      "related": "ABBV",
      "source": "SeekingAlpha",
      "summary": "Merck remains a top Big Pharma name with strong leadership, rising sales, and high margins, despite regulatory fears and pressures. Learn why MRK stock is a buy.",
      "url": "https://finnhub.io/api/news?id=ef8150d08e342399dd1513b3199ce82a7da44d655618d5191c837c31591dc9bb"
    }
  }
]